Antibe Therapeutics Inc. (ATE.TO)
Company Info
| ISIN | CA0370255097 |
|---|---|
| CUSIP | 037025509 |
| Sector | Healthcare |
| Industry | Medical Devices |
ATE.TOShare Price Chart
Click Calculate to get results
ATE.TOPerformance
The chart shows the growth of CA$10,000 invested in Antibe Therapeutics Inc. in Jun 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$1,127 for a total return of roughly -88.73%. All prices are adjusted for splits and dividends.
ATE.TOReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | 3.33% | 8.28% |
| 6M | -8.82% | -9.28% |
| YTD | -6.06% | -14.48% |
| 1Y | -58.94% | -8.58% |
| 5Y | -6.14% | 8.22% |
| 10Y | -21.32% | 8.52% |
ATE.TOMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 3.03% | 8.82% | 6.76% | -16.46% | 4.55% | -11.59% | -1.64% | 3.33% | ||||
| 2021 | -4.33% | 28.99% | 4.95% | -17.29% | -1.19% | -10.82% | -8.63% | -62.83% | -4.76% | -33.33% | -13.75% | -4.35% |
| 2020 | 24.44% | 8.93% | -0.00% | 14.75% | 10.00% | -46.10% | -10.84% | 5.41% | -10.26% | -2.86% | 20.59% | -4.15% |
| 2019 | -6.45% | -5.17% | 3.64% | 22.81% | -7.14% | 3.08% | -16.42% | 41.07% | -1.27% | 25.64% | -22.45% | 18.42% |
| 2018 | 68.97% | 4.08% | 70.59% | -9.20% | -1.27% | -2.56% | -21.05% | -5.00% | 17.54% | -10.45% | -15.00% | 21.57% |
| 2017 | 17.65% | 5.00% | -4.76% | -15.00% | -41.18% | -10.00% | 5.56% | -10.53% | 5.88% | 5.56% | 47.37% | 3.57% |
| 2016 | -8.33% | -0.00% | -24.24% | 12.00% | -7.14% | -3.85% | 28.00% | 53.13% | -14.29% | -11.90% | -13.51% | 6.25% |
| 2015 | -89.00% | 36.36% | 133.33% | 34.29% | -27.66% | -17.65% | -28.57% | -5.00% | 63.16% | -3.23% | 33.33% | -10.00% |
| 2014 | 28.30% | -4.41% | 26.15% | -29.27% | -1.72% | -7.02% | -15.09% | 11.11% | -22.00% | 28.21% | 2.00% | -1.96% |
| 2013 | 0.00% | -0.00% | 0.00% | 1.82% | 16.07% | -3.08% | -15.87% |
ATE.TODividend History
Antibe Therapeutics Inc. doesn't pay dividends
ATE.TODrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
ATE.TOWorst Drawdowns
The table below shows the maximum drawdowns of the Antibe Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Antibe Therapeutics Inc. is 95.29%, recorded on Jan 26, 2015. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.29% | Mar 24, 2014 | 212 | Jan 26, 2015 | — | — | — |
| -20% | Aug 22, 2013 | 80 | Dec 13, 2013 | 32 | Jan 31, 2014 | 112 |
| -12.94% | Mar 10, 2014 | 9 | Mar 20, 2014 | 1 | Mar 21, 2014 | 10 |
| -8.7% | Feb 18, 2014 | 6 | Feb 25, 2014 | 5 | Mar 4, 2014 | 11 |
| -6.9% | Jul 29, 2013 | 11 | Aug 13, 2013 | 6 | Aug 21, 2013 | 17 |
ATE.TOVolatility Chart
Current Antibe Therapeutics Inc. volatility is 61.64%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.